Exploratory Study of Umbilical Cord Blood-Derived CAR-NK Cell Therapy Targeting TRBC1/2 for Relapsed/Refractory T-Cell Lymphoma
Second Affiliated Hospital, School of Medicine, Zhejiang University
Second Affiliated Hospital, School of Medicine, Zhejiang University
Mayo Clinic
Baylor College of Medicine
Ohio State University Comprehensive Cancer Center
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Washington University School of Medicine
Institute of Hematology & Blood Diseases Hospital, China
Wake Forest University Health Sciences
Stanford University
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Stanford University
University of Nebraska
Therapeutic Advances in Childhood Leukemia Consortium
Tianjin Medical University Cancer Institute and Hospital
Peter MacCallum Cancer Centre, Australia
National Cancer Centre, Singapore
Fred Hutchinson Cancer Center
University of Michigan Rogel Cancer Center
Barbara Ann Karmanos Cancer Institute
Washington University School of Medicine
Stanford University
Barbara Ann Karmanos Cancer Institute
M.D. Anderson Cancer Center
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Swiss Cancer Institute
Ohio State University Comprehensive Cancer Center
Virginia Commonwealth University
Case Comprehensive Cancer Center
Ohio State University Comprehensive Cancer Center
Rutgers, The State University of New Jersey
City of Hope Medical Center